Further, the established value of NT-proBNP in identifying cardiac dysfunction, coupled with the utility of PFTs in the assessment of ILD, makes this algorithm a useful tool for dyspnoea evaluation in SSc patients. This evidence concerns the gene NPPB and systemic sclerosis.